NMPA China's GeneMind Biosciences Launches GenoCare 1600 Single-Molecule Sequencer Premium The sequencing-by-synthesis platform, using technology originally developed by Helicos, was approved by China's NMPA for noninvasive prenatal testing earlier this year. Standard BioTools Partner Ascendas Genomics Gets Chinese Approval for MDx Systems The companies partnered in 2017, striking a deal under which Ascendas would develop and commercialize the systems using Standard BioTools technology. Canhelp Genomics Secures NMPA Approval for Pan-Cancer Tissue-Origin Assay, Analysis Software The Canhelp-Origin Test measures the gene expression pattern of 90 specific markers of tissue samples and classifies 21 major tumor types. Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay The OncoReveal Dx Colon Cancer Assay is intended for use on the Illumina MiSeq Dx, and now has approvals in China, the US, and Europe. China NMPA Approves GeneMind GenoCare 1600 Sequencer for Noninvasive Prenatal Testing The sequencer, produced by Chinese sequencing tech company GeneMind Biosciences, is approved for noninvasive prenatal testing to detect common trisomies. Apr 6, 2022 Bionano Genomics Expanding Business in China With Eye Toward Clinical Market Premium Mar 23, 2022 Burning Rock Adds Validation Data as it Begins MRD and Early Detection Commercialization Premium Mar 15, 2022 Burning Rock Secures Lung Cancer NGS Test Regulatory Approval in China Nov 2, 2021 Pacific Biosciences Q3 Revenues Jump 83 Percent Sep 2, 2021 AnPac Bio Developing Multicancer Testing Device Based on Biophysical Properties of Blood Components Premium Aug 23, 2021 AnPac Bio Files Multicancer Detection Device for Registrational Testing With China's NMPA Mar 1, 2021 OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval Dec 2, 2020 China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis Nov 11, 2020 OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio May 20, 2020 Genetron Health, Darui Strike Development Deal for Pathogen Sequencing Tests Mar 30, 2020 Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit Mar 26, 2020 Fosun Long March Gets Chinese Regulatory Approval for Coronavirus MDx Kit Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Feb 11, 2020 Verigene II, New Assay Launches Anticipated to Revivify Luminex Revenues in 2020 Premium Feb 10, 2020 Luminex Q4 Revenues Rise 12 Percent Jan 29, 2020 BGI Sequencer, Coronavirus Molecular Assays Granted Emergency Use Approval in China Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Nov 4, 2019 Biolidics ClearCell FX1 System Gets China NMPA Approval Jul 23, 2019 China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples Apr 11, 2019 Curetis 2018 Revenues Grow 17 Percent Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.